PLTR: Technical Analysis Based on GEX Gamma Feb. 5
376
Key Observations from the GEX:
1. Gamma Exposure (GEX): * CALL GEX Dominance (52.4%): Indicates a relatively bullish sentiment, with more exposure leaning towards upward price momentum. * This suggests market makers might facilitate upward movements until resistance levels are reached.
2. Key Levels: * Highest Positive NETGEX (Resistance): Near $108.91, a critical resistance point where call options could slow further upward momentum. * Immediate Resistance: Around $115, which aligns with the second CALL wall. * PUT Support Zones: At $99, $97, and lower. These levels act as a cushion for downward price movement.
3. Implied Volatility (IV): * IV Rank (IVR): At 53.7, this indicates moderately elevated volatility compared to historical levels. * IVx (Average IV): At 68.8%, implying options are slightly expensive but could offer significant moves.
Potential Trade Scenarios: 1. Bullish Scenario: * If PLTR holds above $101 and breaks above $103, a move toward $108 and potentially $115 is possible. * Suggestion: * Buy 7 (or 9-23) DTE Calls: Strike price $105, targeting $108-$110. * Exit on a clear rejection at $108 or $110.
2. Bearish Scenario: * If PLTR fails to hold above $101 and falls below $99, it could test $97 or lower. * Suggestion: * Buy 7 (or 9-23) DTE Puts: Strike price $100, targeting $97-$95. * Stop loss above $103.
Suggested Trade: * Primary Trade (Bullish): Buy 7 (or 9-23) DTE Calls at $105. * Stop Loss: Below $100. * Take Profit Levels: Partial exit at $108, full exit at $115.
Key Reminders: * The GEX indicator suggests potential upward momentum unless strong resistance levels like $108.91 are reached. * Always check real-time GEX updates during trading to adjust for shifts in gamma exposure.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.